Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学IBD and Cancer Risk, Ulcerative Colitis

Bruce Sands

MD, MS

🏢Icahn School of Medicine at Mount Sinai🌐USA

Dr Burrill B Crohn Professor of Medicine, Chief of Gastroenterology

100
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Bruce Sands is chief of gastroenterology at Mount Sinai and led pivotal trials of tofacitinib, ustekinumab, and ozanimod in ulcerative colitis. He has contributed to safety analyses of long-term IBD therapies including malignancy risk. His work shaped UC therapeutic algorithms and surveillance approaches.

Share:

🧪Research Fields 研究领域

ulcerative colitis
tofacitinib UC
ustekinumab UC
IBD cancer risk
trial endpoints IBD

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Bruce Sands 的研究动态

Follow Bruce Sands's research updates

留下邮箱,当我们发布与 Bruce Sands(Icahn School of Medicine at Mount Sinai)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment